<SEC-DOCUMENT>0001104659-25-056816.txt : 20250605
<SEC-HEADER>0001104659-25-056816.hdr.sgml : 20250605
<ACCEPTANCE-DATETIME>20250605155816
ACCESSION NUMBER:		0001104659-25-056816
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20250605
FILED AS OF DATE:		20250605
DATE AS OF CHANGE:		20250605

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Grifols SA
		CENTRAL INDEX KEY:			0001438569
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35193
		FILM NUMBER:		251026977

	BUSINESS ADDRESS:	
		STREET 1:		1585 BROADWAY
		STREET 2:		SUITE 2376
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036
		BUSINESS PHONE:		212-969-3335

	MAIL ADDRESS:	
		STREET 1:		1585 BROADWAY
		STREET 2:		SUITE 2376
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>tm2517275d1_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="border-top: Black 2pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form&nbsp;6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16 <BR>
UNDER THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the month of June&nbsp;2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Commission File No.&nbsp;001-35193</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Grifols, S.A.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Translation of registrant&rsquo;s name into English)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Avinguda de la Generalitat, 152-158</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Parc de Negocis Can Sant Joan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Sant Cugat del Valles 08174</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Barcelona, Spain</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of registrant&rsquo;s principal executive
office)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant files or will file annual
reports under cover Form&nbsp;20-F or Form&nbsp;40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form&nbsp;20-F <FONT STYLE="font-family: Wingdings">&#120;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form&nbsp;40-F
<FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Grifols, S.A.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">TABLE OF CONTENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Item</B></FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Sequential&nbsp;Page&nbsp;Number</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.25in; text-align: left; width: 10%"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">1.</FONT></A></TD>
    <TD STYLE="text-align: left"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">Other Relevant Information, dated June 5, 2025</FONT></A></TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="text-align: right; width: 15%"><A HREF="#a_001"><FONT STYLE="font-size: 10pt">3</FONT></A></TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD><IMG SRC="tm2517275d1_6kimg001.jpg" ALT="">&nbsp;</TD>
  <TD STYLE="width: 20%"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Grifols,
S.A.<BR>
</B></FONT>Avinguda de la Generalitat 152-158<BR>
 08174 Sant Cugat del Vall&egrave;s<BR>
 Barcelona - ESPA&Ntilde;A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Tel. [34] 935 710 500</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Fax [34] 935 710 267</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><U>www.grifols.com</U></P>

</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0.05pt">Pursuant to the provisions of article 227 of the Law 6/2023,
of March 17, on Securities Markets and Investment Services, Grifols, S.A. (the &quot;<B>Company</B>&quot;) hereby informs about the following</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><A NAME="a_001"></A><B>OTHER RELEVANT INFORMATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36.05pt">(i)</TD><TD STYLE="text-align: justify; padding-right: 1pt">The Ordinary General Shareholders' Meeting held on today's date, on second call, has
passed the proposals submitted to the shareholders' approval.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.05pt; text-align: justify">Furthermore, it is hereby expressly
noted that item 6.5 (<I>Ratification of the appointment by co-option of Mr. Paul S. Herendeen as a member of the Board of Directors</I>),
has not been submitted to a vote given that the minority shareholders FF Hybrid LP, Flat Footed Series LLC-Fund3, GP Recovery Fund LLC,
Mason Capital Master Fund, L.P., and Sachem Head LP have grouped their shares (a total of 8.4% of the Company's voting rights) and have
designated Mr. Paul S. Herendeen as a director in exercise of their right to proportional representation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.05pt; text-align: justify">The complete text of the proposals
is attached hereto as <U>Annex 1</U> and may also be viewed on the Company's website ( <FONT><U>www.grifols.com</U></FONT>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 36.05pt">(ii)</TD><TD STYLE="text-align: justify; padding-right: 1pt">The Company's Board of Directors, at its meeting held today 5 June 2025 after the
Ordinary General Shareholders' Meeting, has unanimously resolved the following:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.4pt"></TD><TD STYLE="width: 21.65pt">(a)</TD><TD STYLE="text-align: justify">to appoint Mrs. Anne-Catherine Berner as new Chairperson of the Company's Board of Directors;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.4pt"></TD><TD STYLE="width: 21.65pt">(b)</TD><TD STYLE="text-align: justify; padding-right: 1pt">to remove the position of Lead Independent Director of the Board of Directors, role
held by Mrs. Montserrat Mu&ntilde;oz Abellana, given the Chairperson of the Board is now an independent Board member and, thus, such position
is not mandatory by law;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 35.4pt"></TD><TD STYLE="width: 21.65pt">(c)</TD><TD STYLE="text-align: justify; padding-right: 1pt">to reorganize the Committees of the Board so that, as of the date hereof, they are
composed as follows, as well as re-naming the Sustainability Committee as the &quot;<I>Sustainability, Communication and Reputation Committee</I>&quot;:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.05pt; text-align: justify"><B><I><U>Audit Committee </U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 82%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
<TD STYLE="border-top: black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; padding-top: 5pt; width: 35%; text-align: center; font-size: 10pt; padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Director</I></B></FONT></TD>
<TD STYLE="border-top: black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; width: 30%; text-align: center; font-size: 10pt; padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Position</I></B></FONT></TD>
<TD STYLE="border-top: black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; width: 35%; text-align: center; font-size: 10pt; padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Category</I></B></FONT></TD>
</TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="border-right: Black 1pt solid; padding-top: 5pt; border-bottom: Black 1pt solid; border-left: black 1pt solid; text-align: center; padding-bottom: 5pt">Mr. &Iacute;&ntilde;igo S&aacute;nchez-Asia&iacute;n Mardones &nbsp;</TD>
<TD STYLE="border-right: Black 1pt solid; padding-top: 5pt; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 5pt">Chairperson</TD>
<TD STYLE="border-right: Black 1pt solid; padding-top: 5pt; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 5pt">Independent </TD>
</TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="border-right: Black 1pt solid; padding-top: 5pt; border-bottom: Black 1pt solid; border-left: black 1pt solid; text-align: center; padding-bottom: 5pt">Mrs. Montserrat Mu&ntilde;oz Abellana &nbsp;</TD>
<TD STYLE="border-right: Black 1pt solid; padding-top: 5pt; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 5pt">Member </TD>
<TD STYLE="border-right: Black 1pt solid; padding-top: 5pt; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 5pt">Independent </TD>
</TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="border-right: Black 1pt solid; padding-top: 5pt; border-bottom: Black 1pt solid; border-left: black 1pt solid; text-align: center; font-size: 10pt; padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Pascal Ravery</FONT></TD>
<TD STYLE="border-right: Black 1pt solid; padding-top: 5pt; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member</FONT></TD>
<TD STYLE="border-right: Black 1pt solid; padding-top: 5pt; border-bottom: Black 1pt solid; text-align: center; font-size: 10pt; padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent</FONT></TD>
</TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="border-right: Black 1pt solid; padding-top: 5pt; border-bottom: Black 1pt solid; border-left: black 1pt solid; text-align: center; padding-bottom: 5pt">Mrs. Laura de la Cruz Gal&aacute;n &nbsp;</TD>
<TD STYLE="border-right: Black 1pt solid; padding-top: 5pt; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 5pt">Secretary (non- member) </TD>
<TD STYLE="border-right: Black 1pt solid; padding-top: 5pt; border-bottom: Black 1pt solid; text-align: center; padding-bottom: 5pt">&nbsp; &nbsp; &nbsp;</TD>
</TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2517275d1_6kimg001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.05pt; text-align: justify"><B><I><U>Appointments and Remuneration Committee</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 82%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
<TD STYLE="border-top: black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; border-left: black 1pt solid; width: 35%; text-align: center; font-size: 10pt; padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Director</I></B></FONT></TD>
<TD STYLE="border-top: black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; width: 30%; text-align: center; font-size: 10pt; padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Position</I></B></FONT></TD>
<TD STYLE="border-top: black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; width: 35%; text-align: center; font-size: 10pt; padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Category</I></B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; padding-top: 5pt; text-align: center; padding-bottom: 5pt">Mrs. Montserrat Mu&ntilde;oz Abellana &nbsp;</TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; text-align: center; padding-bottom: 5pt">Chairperson </TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; text-align: center; padding-bottom: 5pt">Independent </TD></TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; padding-top: 5pt; text-align: center; padding-bottom: 5pt">Mrs. Susana Gonz&aacute;lez Rodr&iacute;guez &nbsp;</TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; text-align: center; padding-bottom: 5pt">Member </TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; text-align: center; padding-bottom: 5pt">Independent </TD></TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; padding-top: 5pt; text-align: center; padding-bottom: 5pt">Mr. Tom&aacute;s Dag&aacute; Gelabert &nbsp;</TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; text-align: center; padding-bottom: 5pt">Member &nbsp;</TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; text-align: center; padding-bottom: 5pt">Other External &nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; padding-top: 5pt; text-align: center; padding-bottom: 5pt">Mr. V&iacute;ctor Grifols Deu &nbsp;</TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; text-align: center; padding-bottom: 5pt">Member &nbsp;</TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; text-align: center; padding-bottom: 5pt">Proprietary &nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; padding-top: 5pt; text-align: center; font-size: 10pt; padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Paul S. Herendeen</FONT></TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; text-align: center; padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member</FONT></TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; text-align: center; font-size: 10pt; padding-bottom: 5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proprietary</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; padding-top: 5pt; text-align: center; padding-bottom: 5pt">Mrs. N&uacute;ria Mart&iacute;n Barn&eacute;s &nbsp; &nbsp;</TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; text-align: center; padding-bottom: 5pt">Secretary (non- member) &nbsp;</TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; text-align: center; padding-bottom: 5pt">&nbsp; &nbsp; &nbsp; &nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 57.05pt; text-align: justify"><B><I><U>Sustainability, Communication and Reputation Committee</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 82%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
<TD STYLE="border-top: black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; padding-top: 5pt; padding-bottom: 5pt; width: 35%; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Director</I></B></FONT></TD>
<TD STYLE="border-top: black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; padding-bottom: 5pt; width: 30%; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Position</I></B></FONT></TD>
<TD STYLE="border-top: black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; padding-bottom: 5pt; width: 35%; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><I>Category</I></B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; padding-top: 5pt; padding-bottom: 5pt; text-align: center">Mrs. Susana Gonz&aacute;lez Rodr&iacute;guez &nbsp;</TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; padding-bottom: 5pt; text-align: center">Chairperson </TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; padding-bottom: 5pt; text-align: center">Independent </TD></TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; padding-top: 5pt; padding-bottom: 5pt; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mrs. Enriqueta Felip Font</FONT></TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; padding-bottom: 5pt; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member</FONT></TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; padding-bottom: 5pt; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; padding-top: 5pt; padding-bottom: 5pt; text-align: center">Mrs. Anne-Catherine Berner &nbsp;</TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; padding-bottom: 5pt; text-align: center">Member </TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; padding-bottom: 5pt; text-align: center">Independent </TD></TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; padding-top: 5pt; padding-bottom: 5pt; text-align: center">Mr. Albert Grifols Coma- Cros &nbsp;</TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; padding-bottom: 5pt; text-align: center">Member </TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; padding-bottom: 5pt; text-align: center">Proprietary </TD></TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; padding-top: 5pt; padding-bottom: 5pt; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr. Raimon Grifols Roura</FONT></TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; padding-bottom: 5pt; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Member</FONT></TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; padding-bottom: 5pt; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proprietary</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: black 1pt solid; padding-top: 5pt; padding-bottom: 5pt; text-align: center">Mrs. N&uacute;ria Mart&iacute;n Barn&eacute;s &nbsp; &nbsp;</TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; padding-bottom: 5pt; text-align: center">Secretary (non- member) &nbsp;</TD>
<TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-top: 5pt; padding-bottom: 5pt; text-align: center">&nbsp; &nbsp; &nbsp; &nbsp;</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2517275d1_6kimg001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In Barcelona, on 5 June 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="border-top: Black 1pt solid; width: 50%">Ms. N&uacute;ria Mart&iacute;n Barn&eacute;s <BR>
Secretary to the Board of Directors</TD>
  <TD STYLE="width: 50%">&nbsp;</TD></TR>
</TABLE>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2517275d1_6kimg001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>ANNEX I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>GRIFOLS, S.A.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>PROPOSED RESOLUTIONS TO BE SUBMITTED TO THE GENERAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>SHAREHOLDERS' MEETING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>(4 / 5 June 2025)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left; width: 70.85pt"><B><U>First.</U></B></TD>
  <TD STYLE="text-align: left"><B><U>Review and approval, as the case may be, of the individual annual accounts and management report, as well as the proposal for allocation
of results relating to the fiscal year ended December 31, 2024</U>.</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.85pt"></TD><TD STYLE="width: 28.15pt">A.</TD><TD STYLE="text-align: justify; padding-right: 1pt">To approve the Company&rsquo;s individual annual accounts, which are composed of the
balance sheet, the profit and loss account, the statement of changes in net equity, the cash flow statement and the annual report, as
well as the individual management report, relating to the fiscal year ended December 31, 2024, which show losses in thousands of Euros
of EUR 83,138.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">The Company's individual annual accounts
correspond to the audited accounts and will be deposited with the Commercial Registry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.85pt"></TD><TD STYLE="width: 28.15pt">B.</TD><TD STYLE="text-align: justify">In accordance with the submitted annual accounts, to approve the following allocation of results in thousands
of Euros:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 84%; margin-left: 99pt">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 75%; text-align: left">To Voluntary Reserve:</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%">EUR</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(83,138</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif">TOTAL</TD><TD STYLE="font: italic 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif">EUR</TD>
    <TD STYLE="font: italic 10pt Times New Roman, Times, Serif; text-align: right">(83,138</TD><TD STYLE="font: italic 10pt Times New Roman, Times, Serif; text-align: left">)</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left; width: 70.85pt"><B><U>Second. </U></B></TD>
  <TD STYLE="text-align: left"><B><U>Review and approval, as the case may be, of the consolidated annual accounts and management report relating to the fiscal year
ended December 31, 2024</U>.</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71pt; text-align: justify">To approve the consolidated annual accounts
of the Group, which are composed of the consolidated balance sheet, the profit and loss account, the statement of changes in net equity,
the cash flow statement and the annual report, as well as the management report of the Group, relating to the fiscal year ended December
31, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71pt; text-align: justify">The Company's consolidated annual accounts
correspond with the audited accounts and will be deposited with the Commercial Registry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 70.85pt"><B><U>Third. </U></B></TD>
  <TD STYLE="text-align: justify"><B><U>Review and approval, as the case may be, of the consolidated non-financial information statement included in the consolidated management
report relating to the fiscal year ended December 31, 2024</U>.</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71pt; text-align: justify">To approve the consolidated non-financial
information statement included in the consolidated management report relating to the fiscal year ended December 31, 2024. Such statement
has been subject to verification in accordance with the current regulations.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2517275d1_6kimg001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 70.85pt"><B><U>Fourth. </U></B></TD>
  <TD STYLE="text-align: justify"><B><U>Review and approval, as the case may be, of the performance of the Board of Directors throughout the fiscal year ended December
31, 2024</U>.</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71pt; text-align: justify">To approve the management of the Board of Directors, at
both Company and Group level, throughout the fiscal year ended December 31, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71pt; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 70.85pt"><B><U>Fifth. </U></B></TD>
  <TD STYLE="text-align: justify"><B><U>Appointment of Deloitte Auditores, S.L. as the independent assurance services provider (<I>verificador de la informaci&oacute;n
sobre sostenibilidad</I>) of the Company and its consolidated group to carry out the assurance of sustainability information (<I>para
realizar la verificaci&oacute;n de la informaci&oacute;n sobre sostenibilidad</I>) corresponding to fiscal years 2025-2027, inclusive,
subject to certain conditions precedent</U>.</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71pt; text-align: justify">Subject to the conditions precedent
described below, appoint as independent assurance services provider (<I>verificador de la informaci&oacute;n sobre sostenibilidad</I>)
of the Company and its consolidated group to carry out the assurance of sustainability reporting (<I>para realizar la verificaci&oacute;n
de la presentaci&oacute;n de informaci&oacute;n sobre sostenibilidad</I>), Deloitte Auditores, S.L., registered in the Official Registry
of Auditors (<I>Registro Oficial de Auditores de Cuentas del Instituto de Contabilidad y Auditor&iacute;a de Cuentas</I>) under number
S0692, with registered office in Madrid, Plaza Pablo Ruiz Picasso n&uacute;mero 1, Torre Picasso, registered in the Commercial Registry
of Madrid, under Volume 13,650, Section 8, Folio 188, Sheet M-54414, inscription 96, and provided with Tax Identification Card number
B-79104469, for a term of three years, that is, for the fiscal years 2025, 2026, and 2027, inclusive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71pt; text-align: justify">The effectiveness of this appointment
is subject to the fulfillment of the following conditions precedent:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.85pt"></TD><TD STYLE="width: 28.15pt">A.</TD><TD STYLE="text-align: justify">In the event that any of the following two circumstances occurs:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 25pt">i.</TD><TD STYLE="text-align: justify">the approval of the law transposing Directive (EU) 2022/2464 of the European Parliament and of the Council
of December 14, 2022 amending Regulation (EU) No 537/2014, Directive 2004/109/EC, Directive 2006/43/EC, and Directive 2013/34/EU, as regards
corporate sustainability reporting (the &ldquo;<B>Directive</B>&#750;) within the fiscal year 2025; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 25pt">ii.</TD><TD STYLE="text-align: justify; padding-right: 1pt">in the absence of approval of a transposing law of the Directive, the direct application
within the fiscal year 2025 of the provisions of the Directive, provided that said Directive meets the necessary conditions to be directly
applicable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.85pt"></TD><TD STYLE="width: 28.15pt">B.</TD><TD STYLE="text-align: justify">The requirement, pursuant to (i) the Directive, or (ii) the law implementing the Directive, to
                                                            appoint an independent assurance services provider (<I>verificador de la informaci&oacute;n sobre sostenibilidad</I>) of the Company
                                                            to carry out the assurance of sustainability reporting for
fiscal year 2025.</TD></TR></TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2517275d1_6kimg001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71pt; text-align: justify">Likewise, authorize the Chairman, the
Chief Executive Officer, the Secretary non-member and the Vice Secretary non-member of the Board of Directors so that any of them, individually
and joint and severally, may complete, complement, and/or develop this appointment as necessary and, specifically, to comply with the
legal provisions in force at the time of fulfilling the aforementioned conditions precedent for the effective formalization and execution
of this resolution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 70.85pt"><B><U>Sixth. </U></B></TD>
  <TD STYLE="text-align: justify"><B><U>Dismissal, resignation and re-election and/or appointment or ratification, as the case may be, of the members of the Board of Directors.
Modification, if applicable, of the number of members of the Board of Directors</U>:</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.85pt"></TD><TD STYLE="width: 28.15pt"><B>6.1.</B></TD><TD STYLE="text-align: justify; padding-right: 1pt"><B>Information on the non re-election of Mr. Thomas Glanzmann to his position as a
member of the Board of Directors. </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">As anticipated in the communication
of Other Relevant Information to the CNMV dated 25 February 2025, acknowledge that the Company's Board of Directors has not proposed the
re-election of Mr. Thomas Glanzmann to his position as a member of the Company's Board of Directors, at his request as communicated by
him to the Board of Directors, after having served as a director of Grifols for 19 years. The Board of Directors thanks him for the services
provided up to date and approves his performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.85pt"></TD><TD STYLE="width: 28.15pt"><B>6.2.</B></TD><TD STYLE="text-align: justify"><B>Amendment of the number of members of the Board of Directors. </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">As anticipated in the communication
of Other Relevant Information to the CNMV dated 25 February 2025, it is resolved to reduce the number of members of the Board of Directors
to twelve (12) members.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">In case that any of the resolutions
proposed under items 6.3, 6.4 and 6.5 below is not adopted, the number of members of the Board of Directors shall be further reduced to
the effective number of directors actually on board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.85pt"></TD><TD STYLE="width: 28.15pt"><B>6.3</B></TD><TD STYLE="text-align: justify; padding-right: 1pt"><B>Re-election of Mr. V&iacute;ctor Grifols Deu as a member of the Board of Directors.
</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">To re-elect Mr. V&iacute;ctor Grifols
Deu as a member of the Board of Directors for a term of four (4) years and with effects as of the date of this General Shareholders' Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">It is expressly stated that this
proposal has the favorable report from the Appointments and Remuneration Committee, and in accordance with said report from the Committee,
Mr. Grifols Deu will continue to be considered as a &ldquo;proprietary&#750; director.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2517275d1_6kimg001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">In order to approve this resolution,
the shareholders shall be provided with this proposal, the Board of Directors' report regarding the competence, experience and merits
of the director and the abovementioned report of the Appointments and Remuneration Committee, in compliance with the Capital Companies
Act (<I>Ley de Sociedades de Capital</I>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.85pt"></TD><TD STYLE="width: 28.15pt"><B>6.4.</B></TD><TD STYLE="text-align: justify; padding-right: 1pt"><B>Ratification of the appointment by co-option of Mr. Pascal Ravery as a member of
the Board of Directors. </B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">To ratify, prior proposal of the Appointments
and Remuneration Committee, the appointment of Mr. Pascal Ravery by the co-option procedure, in accordance with the Board of Director's
resolution dated 8 December 2024, who accepted on 9 December 2024, as a member of the Board of Directors of the Company. His term of office
ends on 14 June 2028, which corresponds to the term of the previous director whom he replaced.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">It is expressly stated that, according
to said proposal of the Committee, Mr. Ravery will continue to be considered as an &ldquo;independent&#750; director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">In order to approve this resolution,
the shareholders shall be provided with this proposal and with the Board of Directors' report regarding the competence, experience and
merits of the director, in compliance with the Capital Companies Act (<I>Ley de Sociedades de Capital</I>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.85pt"></TD><TD STYLE="width: 28.15pt"><B>6.5.</B></TD><TD STYLE="text-align: justify"><B>Ratification of the appointment by co-option of Mr. Paul S. Herendeen as a member of the Board of Directors.
</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">This item has not been submitted to
a vote as the shareholders FF Hybrid LP, Flat Footed Series LLC-Fund3, GP Recovery Fund LLC, Mason Capital Master Fund, L.P., and Sachem
Head LP designated Mr. Paul S. Herendeen as a director in exercise of their right to proportional representation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 70.85pt"><B><U>Seventh.</U></B></TD>
  <TD><B><U>Amendment of article 7 of the Regulations of the General Shareholders' Meeting</U>.</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 70.85pt; text-align: justify">In view of the mandatory report of
the Board of Directors, amend article 7 of the Regulations of the General Shareholders' Meeting, consisting on the competences of the
General Shareholders' Meeting to adequate its content to the applicable law currently in force, as well as for introducing technical improvements
in its wording.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2517275d1_6kimg001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 70.85pt; text-align: justify">The mentioned article will read as follows (<I>in italics</I>):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 70.85pt; text-align: justify"><B><I><U>Article 7 . Competence of the General Meeting</U></I></B></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.85pt"></TD><TD STYLE="width: 28.15pt"><I>1.</I></TD><TD STYLE="text-align: justify"><I>The General Shareholders&rsquo; Meeting, duly called and summoned, shall decide on all matters relating
to its competence, in accordance with the Law and the Articles of Association. </I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.85pt"></TD><TD STYLE="width: 28.15pt"><I>2.</I></TD><TD STYLE="text-align: justify"><I>In particular, the General Shareholders&rsquo; Meeting shall be in charge of passing the following
resolutions: </I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 28.8pt"><I>(a)</I></TD><TD STYLE="text-align: justify; padding-right: 1pt"><I>the approval, as the case may be, of the corporate management and of the annual
accounts and the allocation of the results; </I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 28.8pt"><I>(b)</I></TD><TD STYLE="text-align: justify; padding-right: 1pt"><I>the appointment and dismissal of the members of the Board of Directors; </I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 28.8pt"><I>(c)</I></TD><TD STYLE="text-align: justify; padding-right: 1pt"><I>the appointment and removal, in accordance with the legal requirements, of the
Auditors; </I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 28.8pt"><I>(d)</I></TD><TD STYLE="text-align: justify"><I>the amendment of the Articles of Association; </I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 28.8pt"><I>(e)</I></TD><TD STYLE="text-align: justify"><I>the increase and reduction of the share capital, with suppression, if applicable, of the preferential
subscription right; the delegation to the Board of Directors, within the terms foreseen by law, of the authority to set the date or dates
for the execution of the agreed capital increase; the authorisation to the Board of Directors to increase the capital pursuant to the
provisions contained in article 297.1.b of the Companies Act (Ley de Sociedades de Capital); </I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 28.8pt"><I>(f)</I></TD><TD STYLE="text-align: justify"><I>the transformation, merger, split-off and dissolution of the Company, as well as those transactions
with an effect equal to the liquidation of the Company; </I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 28.8pt"><I>(g)</I></TD><TD STYLE="text-align: justify"><I>the establishment, pursuant to any legal requirements, of the remuneration policy of the Board of Directors,
which shall be aligned with the remuneration system established in the articles of association, and the application, as the case may be,
of remuneration systems for board members based on the delivery of shares, option rights over shares, or incentives related to the value
of the Company shares; </I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 28.8pt"><I>(h)</I></TD><TD STYLE="text-align: justify"><I>the authorisation for the derivative acquisition of own shares; </I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 28.8pt"><I>(i)</I></TD><TD STYLE="text-align: justify; padding-right: 1pt"><I>the exercise of the Company&rsquo;s action for liability, according to requirements
established by Law; </I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 28.8pt"><I>(j)</I></TD><TD STYLE="text-align: justify"><I>the approval and amendment of the Regulations of the General <I>Shareholders&rsquo; Meeting; </I></I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 28.8pt"><I>(k)</I></TD><TD STYLE="text-align: justify"><I>the creation of a corporate web page; </I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 28.8pt"><I>(l)</I></TD><TD STYLE="text-align: justify; padding-right: 1pt"><I>the acquisition, transfer or contribution of essential assets to another company;
</I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 28.8pt"><I>(m)</I></TD><TD STYLE="text-align: justify"><I>the transfer to controlled entities of essential activities developed until that point by the Company,
although the Company retains full control of said entities; </I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 28.8pt"><I>(n)</I></TD><TD STYLE="text-align: justify"><I>the approval of related-party
                                            transactions whose amount or value is equal to or higher than that established by Law from
                                            time to time; and</I></TD></TR></TABLE>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 28pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>(o)</I></FONT></TD><TD STYLE="padding-right: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>any other matter attributed to it by law of
by the Articles of Association.</I></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Split-Segment; Name: 1 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"><IMG SRC="tm2517275d1_6kimg001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 70.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Eighth.</U></B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Consultative vote on the Annual Remuneration Report</U>.</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71pt; text-align: justify; text-indent: 0.25pt">Pursuant to the
provisions of article 541.4 of the Capital Companies Act (<I>Ley de Sociedades de Capital</I>), to submit the Annual Remuneration Report
to a consultative vote of the General Shareholders&rsquo; Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 70.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Ninth.</U></B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Approval of the directors' remuneration policy of the
Company</U>.</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 71pt; text-align: justify">In accordance with article 529 <I>novodecies</I>
of the Capital Companies Act (<I>Ley de Sociedades de Capital</I>) and prior to the report by the Appointments and Remuneration Committee,
approve the directors' remuneration policy of the Company (the &quot;<B>Policy</B>&quot;) that was made available to the shareholders
at the time of calling of this General Shareholders' Meeting. The new Policy will be applicable from the date of its approval by this
General Shareholders' Meeting until fiscal year 2028, included.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 70.85pt"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B><U>Tenth.</U></B></FONT></TD>
  <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Approval of a 2025 Equity Incentive Plan</U>.</B></FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 70.85pt"></TD><TD STYLE="width: 28.15pt">A.</TD><TD STYLE="text-align: justify">To approve a long-term variable compensation plan based on the award of shares (the &ldquo;<B>2025 Equity
Incentive Plan</B>&rdquo; or the &ldquo;<B>Plan</B>&rdquo;) for the members of the senior management team and other key employees of the
Company and its affiliates (together with the Company, &ldquo;<B>Grifols</B>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify">The Plan, offered on a one-time basis,
will be implemented under the following basic terms and conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt"><B>1. Participants</B>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">The participants of the Plan include
members of the senior management team of Grifols, as well as selected company executives (others) (the &ldquo;<B>Participants</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">Currently, the group of potential Participants
is composed of approximately 35 individuals, 11 of them members of the senior management team.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">As explained in the Company's Remuneration
Policy, the Company's Chief Executive Officer is not a participant of the Plan, nor is the Chief Financial Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify">Eligibility of any new Participants who
are members of the senior management team will be decided by the Company's Appointments and Remuneration Committee. A special committee
led by the Company's Chief Executive Officer will have the authority to grant awards for Participants who are not members of the senior
management team.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2517275d1_6kimg001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt"><B>2. Purpose of the Plan</B>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 99pt">The 2025 Equity Incentive Plan has been designed to
align the interests of Participants with those of the Company&rsquo;s shareholders and to support the Company&rsquo;s long-term
success by encouraging sustainable value creation. It aims to attract, retain and motivate key talent in an increasingly competitive
global environment, foster long-term commitment to the Company&rsquo;s strategic objectives, and reinforce a compensation strategy
that is aligned with prevailing market standards. In addition, the Plan is structured to meet the expectations of proxy advisors and
institutional investors, and addresses the identified gap in the Company&rsquo;s total compensation offering, particularly for
certain critical roles and geographies. The Plan is intended as a highly selective, performance-linked incentive that complements
existing short-term remuneration structures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt"><B>3. Instruments:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">For the Participants who are
members of the senior management team, the Plan exclusively provides for the grant of performance share units (&ldquo;<B>Performance
Shares</B>&rdquo;), with the purpose of aligning the remuneration of senior executives with the interests of shareholders and the
long-term strategic goals of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">For the Participants who are not members
of the senior management team, the Plan provides for the grant of: (i) Performance Shares (65% of the award) and (ii) fidelity shares
(35% of the award). These two award vehicles are designed to serve complementary purposes, reinforcing both retention and performance-based
reward within a unified long-term incentive framework.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt"><B>4. Term of the Plan:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">The Plan shall have a minimum vesting
period of three (3) years from the grant date (29 April 2025), subject to the approval of the Ordinary Meeting. Vesting will therefore
take place on 29 April 2028.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt">Awards shall not vest earlier than three (3) years after the
date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt"><B>5. Maximum number of shares:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify"><FONT STYLE="font-size: 10pt">The maximum
number of Class A shares of the Company that may be delivered under the Plan shall be 1,032,671 (based on a reference price per share
of &euro;9.017<SUP>1</SUP>), corresponding to a maximum total cost of &euro;9,311,594.12.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><SUP>1</SUP> <B>NTD</B>: <I>the reference price being the average of
share price in Mercado Continuo prior 90 trading days from 28<SUP>th</SUP> April, 2025.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2517275d1_6kimg001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt"><B>6. Requirements and conditions for the delivery of the shares:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify">The specific number of shares within the
established maximum that will be delivered to the Participants at the end of the Plan will be subject to and determined based on the achievement
of the set objectives for the Participant in each case.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify">The proposed percentages have been defined
with a conservative approach, balancing market competitiveness with internal equity and sustainability.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 6.8pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify; padding-right: 1pt"><B>50% </B>Base Salary for senior management team for the entire three years of the
Plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 6.8pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>35% </B>Base Salary for other executives for the entire three years of the Plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">These percentages have been defined considering
total compensation benchmarking.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify">The specific payout for the Participants who are
members of the senior management team will be decided by the Board of Directors prior proposal of the Company's Appointments and Remuneration
Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">The specific payout for the Participants
who are not members of the senior management team will be decided by the special committee led by the Company's Chief Executive Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt">Awards shall be subject to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 25pt">a.</TD><TD STYLE="text-align: justify; padding-right: 1pt">the Participant&rsquo;s continuous service within the Group during the Term of the
Plan;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 25pt">b.</TD><TD STYLE="text-align: justify">having achieved an average annual performance evaluation of at least &ldquo;3&rdquo; out of &ldquo;5&rdquo;
under Grifols' Performance System, which is the global process used to evaluate employee performance, assess potential and ensure constructive
feedback about competences and professional development. The process gives to employee and manager the opportunity to work collaboratively
on setting goals, identifying development opportunities, and understanding how the individual work aligns with the larger organizational
objectives; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 25pt">c.</TD><TD STYLE="text-align: justify; padding-right: 1pt">in the case of Performance Shares, the attainment of the relevant performance metrics
for the applicable performance period based on relative total shareholder return (&ldquo;<B>TSR</B>&rdquo;) as compared to a defined peer
group, as explained below.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2517275d1_6kimg001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt">7. Performance Metrics for Performance Shares:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">The vesting of Performance Shares under
the Plan shall be subject to the attainment of specific performance objectives over the applicable performance period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify">For the members of the senior management team,
the performance criteria is exclusively 100% linked to relative TSR (&ldquo;<B>Relative TSR</B>&rdquo;)<B>.</B> Relative TSR compares
the Company&rsquo;s total shareholder return (including share price appreciation and dividends) against a pre-defined peer group of companies
operating in the biotechnology and pharmaceutical industries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify">Following a detailed assessment, Relative TSR
was selected as the most suitable performance metric. This decision was based on its strong alignment with shareholder value creation
and its wide adoption in the market.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">Relative TSR directly links a portion
of compensation to the Company's ability to create sustainable value for shareholders, as measured against a relevant peer group. Additionally,
Relative TSR as performance indicators is widely recognized and adopted in long-term incentive plans among leading companies, ensuring
competitiveness and alignment with global standards. Furthermore, this metric provide a clear and measurable framework to assess performance,
which enhances internal accountability and external credibility.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">The following payout curve shall apply
to the Relative TSR metric, based on Grifols&rsquo; position within the peer group ranking:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 6.8pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">Below the 40th percentile (position below 8): 0% payout</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 6.8pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">40th to 60th percentile (positions 8 to 11): 60% payout</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 6.8pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">60th to 75th percentile (positions 12 to 14): 100% payout</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 6.8pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">75th to 85th percentile (positions 15 to 16): 120% payout</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 6.8pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">90th percentile and above: 150% payout</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">The peer group has been selected to reflect
companies that: (i) operate on a global scale in the biotech or pharma sectors, (ii) develop and commercialize end-to-end drug solutions
or excipients, (iii) are comparable in terms of business model and geographic presence and (iv) are not involved in medical devices, OTC
products, veterinary medicine, or healthcare services.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt">The peer group includes entities from two sources:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 99pt">&nbsp;</TD>
  <TD STYLE="text-align: justify; width: 25pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Companies included in the ISS P4P peer group for Grifols; and</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1pt"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2517275d1_6kimg001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 25pt">ii.</TD><TD STYLE="text-align: justify">Additional Grifols-selected comparables operating internationally or in similar markets and considered
relevant to its main business, operating model and investor base.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">This performance measure ensures alignment
between executive rewards and shareholder value, and provides an objective, market-based assessment of long-term value creation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify">The peer group used for assessing Relative
TSR includes the following companies: <I>CSL, Lonza, Takeda Pharmaceutical, UCB, Bayer, Biogen, BioMerieux, Genmab, Moderna, Recordati,
Eurofins, Ipsen, Jazz Pharmaceuticals, Hikma, Richter Gedeon Lundbeck, Organon &amp; Co, Bausch Health.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify">These companies were selected based
on their relevance to Grifols&acute; operation model and industry positioning an include members of the ISS P4P peer group, and other
companies chosen by Grifols as appropriate market comparators. ISS creates peer groups based on revenues and sector. Companies included
in Grifols' peer group is based on business similarities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">The special committee may update or
adjust the peer group if needed, to reflect changes in industry conditions or corporate structure, ensuring continued alignment with the
principles outlines herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt"><B>8. Determination of level of achievement and payout:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify">For Participants who are members of
the senior management team, the Appointments and Remuneration Committee will monitor the objectives and the level of achievement will
be determined by the Board of Director's upon recommendation by the Appointments and Remuneration Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 99pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">For Participants who are not members
of the senior management team, the special committee led by the Company's Chief Executive Officer will monitor the objectives and determine
their level of achievement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 99pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt; text-align: justify">The Plan&rsquo;s payment curve allows
for payouts ranging from 0% to 150% of the target award, depending on the level of achievement of the performance criteria.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 99pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">The specific payout for Participants
who are members of the senior management team will be decided by the Board of Directors prior proposal of the Company's Appointments and
Remuneration Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 99pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">The specific payout for the Participants
who are not members of the senior management team will be decided by the special committee led by the Company's Chief Executive Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify"></P>

<!-- Field: Page; Sequence: 15; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: justify"><IMG SRC="tm2517275d1_6kimg001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 99pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt"><B>9. Holding period and clawback:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 99pt">The Plan includes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 6.8pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">A holding period of one (1) year following delivery of vested shares, unless the Participant maintains
property, at the time of the intended transfer, of sufficient shares equivalent in value to an amount of at least twice his or her fixed
annual remuneration through the ownership of shares, options or other financial instruments.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 6.8pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">A clawback provision, requiring the return of awards or their cash equivalent in case of fraud, unethical
behavior or errors in the performance metrics that led to vesting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 60pt"></TD><TD STYLE="width: 38pt">B.</TD><TD STYLE="text-align: justify">To authorize the Board of Directors, with express powers of substitution, to implement, develop, formalize,
execute and, where appropriate, modify the Plan, adopting any resolutions and signing any documents that may be necessary or advisable
for its full effectiveness, including, without limitation, the following powers:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 20.8pt; text-align: left">1.</TD><TD STYLE="text-align: justify">To formalize and execute the Plan at its discretion and in the
manner it deems appropriate, and to take any actions necessary or advisable for its effective implementation.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 20.8pt">2.</TD><TD STYLE="text-align: justify; padding-right: 1pt">To develop and establish the specific conditions of the Plan in all aspects not provided
for in this resolution, including the power to determine the consequences of a change of control, early settlement events, and fulfilment
of any applicable vesting conditions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 20.8pt">3.</TD><TD STYLE="text-align: justify; padding-right: 1pt">To interpret, clarify, correct and complete the Plan in all aspects not expressly
addressed in this resolution.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 20.8pt">4.</TD><TD STYLE="text-align: justify; padding-right: 1pt">To adapt the content of the Plan and take any actions needed to ensure its alignment
with applicable laws, macroeconomic or corporate changes, or best market practices.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 20.8pt">5.</TD><TD STYLE="text-align: justify; padding-right: 1pt">To draft and submit to any relevant authorities or entities any communications, documentation
or prospectuses necessary for the implementation or execution of the Plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 20.8pt">6.</TD><TD STYLE="text-align: justify; padding-right: 1pt">To adopt, execute and formalize any public or private documents deemed necessary or
advisable for the full implementation and development of the Plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 20.8pt">7.</TD><TD STYLE="text-align: justify; padding-right: 1pt">To determine the mechanisms for the delivery or acquisition of the Class A shares
under the Plan and the appropriate funding arrangements, if needed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2517275d1_6kimg001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 20.8pt">8.</TD><TD STYLE="text-align: justify; padding-right: 1pt">To decide not to implement the Plan or any part thereof, or to exclude certain Participants
where circumstances so require.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 99pt"></TD><TD STYLE="width: 20.8pt">9.</TD><TD STYLE="text-align: justify; padding-right: 1pt">In general, to carry out any actions and execute any documents necessary or advisable
for the validity, effectiveness and successful outcome of the Plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 1in"><B><U>Eleventh.</U></B></TD>
  <TD STYLE="text-align: justify"><B><U>Approval of an inconsistency correction with respect to the stock options over Company shares granted to Mr. Thomas Glanzmann,
approved by the General Shareholders' Meeting on 16 June 2023</U>.</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 1in; text-align: justify">The Ordinary General Shareholders'
Meeting held on 16 June 2023 approved, under resolution &quot;Thirteenth&quot;, the award of stock options over Company shares to Mr.
Thomas Glanzmann, then Executive Chairman of the Company. In said resolution, it was established that the exercise price of the Options
(as defined in said resolution) would be &euro;12.84.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">As an extraordinary measure aimed to
rectify an inconsistency as a matter of fairness, to correct the exercise price of the Options granted to Mr. Thomas Glanzmann for
it to be the same price established under the Stock Option Plan for the senior management team, approved by the same General
Shareholders' Meeting under resolution &quot;Twelfth&quot;, being this price &euro;8.96.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 1in"><B><U>Twelfth.</U></B></TD>
  <TD STYLE="text-align: justify"><B><U>Authorization to the Board of Directors to call, if necessary, Extraordinary General Shareholders' Meetings of the Company with
at least 15 days in advance, in accordance with article 515 of the Capital Companies Act</U>.</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">In accordance with the provisions
of Article 515 of the Capital Companies Act (<I>Ley de Sociedades de Capital</I>), to authorize the call, if so required, of Extraordinary
General Shareholders' Meetings of the Company with at least fifteen (15) days in advance. Said authorization shall be in force until the
next Ordinary General Shareholders' Meeting of the Company is held.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 1in"><B><U>Thirteenth.</U></B></TD>
  <TD STYLE="text-align: justify"><B><U>Authorization for the derivative acquisition of treasury stock, revoking and leaving without effect the authorization agreed by
the Ordinary General Shareholders' Meeting of October 9, 2020</U>.</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">To authorise the Board of Directors
of the Company to acquire the Company&rsquo;s own shares or subscription rights by purchase, exchange, allotment of shares or any other
procedure established by Law, whether directly or through any of its subsidiaries, within the limits and subject to the requirements set
forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify; padding-right: 1pt">That for as long as there are Class B shares, the acquisition between Class A and
Class B shares is made on a pro-rata basis, and under the same terms and conditions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify; padding-right: 1pt">That the nominal value of the acquired shares, including the shares owned by the Company
or its subsidiaries, does not exceed 10% of the share capital of the Company at any time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm2517275d1_6kimg001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">That as a consequence of the acquisition, including the shares that the Company or the shares that any
individual acting in his own name but on behalf of the Company had previously acquired and have become treasury shares, the Company&rsquo;s
equity is not lower than the share capital plus the unavailable reserves required by law or the Company&rsquo;s by-laws.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">That the acquired shares are fully paid-up.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">The maximum acquisition price will be the price of Class A shares listed on the Stock Market on the day
the acquisition takes place or, if applicable, the price permitted by the National Securities Market Commission (<I>Comisi&oacute;n Nacional
del Mercado de Valores</I>). The minimum price will be 100% of the nominal value of each Class A share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(vi)</TD><TD STYLE="text-align: justify">This authorization is granted for a maximum term of five years.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(vii)</TD><TD STYLE="text-align: justify; padding-right: 1pt">The acquired shares may be given to the employees or directors of the Group, either
directly or as the result of exercising the option rights they are entitled to.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Revoke and declare void the previous
authorization for the acquisition of the treasury stock granted by the Ordinary General Shareholders Meeting on October 9, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
  <TD STYLE="width: 1in"><B><U>Fourteenth.</U></B></TD>
  <TD><B><U>Granting of authorities to formalize and execute the resolutions passed by the General Shareholders' Meeting</U>.</B></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">To empower all the members of the
Board of Directors, as well as the Secretary and Vice Secretary non-members, so that any of them, indistinctively, may formalize in
a public deed the resolutions passed at the General Shareholders&rsquo; Meeting, with the authorities to amend, correct or interpret
their wording based on the oral or written evaluation of the Commercial Registry and for the sole purposes of their registration in
the same, being able, as the case may be, to request their partial registration. Said authorization also comprises the granting of
all kinds of public or private documents as may be deemed necessary for the execution, development and formalization of all
resolutions passed at the General Shareholders&rsquo; Meeting, with no limitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">* * * *</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P>

<!-- Field: Page; Sequence: 18; Value: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><U>SIGNATURES</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Grifols,&nbsp;S.A.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ David I. Bell</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="width: 42%"><FONT STYLE="font-size: 10pt">David I. Bell</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Authorized Signatory</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Date:&nbsp; June 5, 2025</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></FONT></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm2517275d1_6kimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2517275d1_6kimg001.jpg
M_]C_X  02D9)1@ ! 0$ R #(  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  Y 00# 2(  A$! Q$!_\0
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M[LK*#3;2WL+.V@MK&QBAL[&UM(U@M[.SM56"RM((@P6..VLHXH B ( -J80
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MFBZ[+;R0RVM['X0\'6_C&XMK>=U>P\2:KX7URT22YTE9+;\2O^"FFL:MJ_\
MP48_;\O-:9Y9XOVQOVG=)M9)&8R+H^B?&GQUI6CQY?<S)#I%G:P0G*AHBA1=
MH7/]HO\ P:/:5IJ_L1?'W5K6&%=5U;]H:[@U&0@>:MK9^&M+.FPS2KEF2(7=
MSY8\L#)=N"V%_KOB]RX3\&L/@\J;PU;$9-D<HUH2Y9N&<K#K'1YZ3]V52G4<
M)<TH/EG*/NJ[/QC)6\XXVQ$L;25:.%GCO9PFXNWLE*--I-I7CORVOUUU/ZQ
M,@ YP",D]=I+<GGIU)]B?K5L'/(Z$ CT[]/Z_A5) P4*S;R."Y^7<"Q(RO)'
M&0/F)/ SSN$Z2Y&  2N%(W'L!\Q^7C)/3GC!R"2!_'D&Z<8*=Y2]FISE%2FW
M*4U&_NW^U*VG1)[:G[/;W4TDHI:+31:_A[N_=^=R5_N-_NM_(U2;HW_74?R6
MO!/$O[6W[,/A#7-:\*^*_P!H/X+^&O$V@71L-:\/ZY\2O"FF:UI-WY2R-;:E
MIEWJ,5Y97"!U9H9HE81LKDC.VO0? _Q.^'GQ1T=O$/PR\<>$OB'X?749-.EU
MSP9XBTKQ'I<6H6X4W%F][I-S>6_VB $&2+S-RGAMO.-Z^%Q4)X:=3#8FG3FZ
MBC4J8>M3IR;H\ZM4J4X4W>*NK3=]+-W5XIU*=6K&-.I3G*/-*454AS17*U=Q
MYKK7R/\ .Q_X.L_^4E?AOW^ 7@S_ -/&H&O:?^#0@$_MP?M2$=!^RJ%[]6^+
M/@$CM@<*>I!] 0&V^*?\'61!_P""EOAP>GP \',.^=NK:B0/H1CGMGIGBM+_
M (-??B9=_!WXY_\ !0+XL66DPZ[=?#+]@OQO\0+;0KB[6P@U>Z\&^-O">NV^
MGS:AY<\EE'=O9M;-<);S)$LS2R(QBB23^M\91J5?H]X3"PBWB*O#^2TZ<+J/
M--YI#"6YY-02^LUJ=/F<N6[YK\D927XOA9QCXA3K-_NX8G$U92LW[BA4=^5+
MF?PO11;\M3_1SFNX8DDN7ECB@MQYDTSR*D:QQH7FE=AO*QPH'=RP7'EL6P@W
MU_D/_P#!5CXB^$?BO_P4D_;.^(O@2XL[SPEKGQMUF#1[NR>)K?47T"UL?#6I
M7T7E,\;M?:GI5W?,\+R*XG\S.YBJ_J1^V?\ \'.W[:G[5GPXUOX5?#CP!X/_
M &9/#WB6RO-(\5:WX1UW5_$WC;5=*G0P26%MK6H6NFC08YXFDCOGTZ-I;F%U
M2)[4^8\OY.?L'?\ !/7]H_\ X*)_%_3?A3\"_">JW&C#4$C^(OQ9U.UNU\$?
M#;2IQ!)?7_B+7S;R_P#$SDL&:XTW3X'OM8U*XG13$@9KP\?A;P7CO#S#YUQ;
MQ/BZ&7.IAOJ$L)/%X6NJ&&DG&K.=3#5:U*5W/W84YU'9WO.HXQ75Q=GE'B*I
MA,DRN$L3*.,<YSC"<7))VTC4C3DG\2::4G9I1;L?V<?\&BOPZUK0OV&?CO\
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MXUQC83CGY,Y.1D$\<>O'.,8/TK\Y?^"K_P"S+H/[7'[ ?[1GPAUBRM[[49?
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M_P#3K;UZ'C';_B%N16VY>"K+LO[/Q=E\D<W ^G%F8+M3Q*_\GJG](Y /!KX
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M9&GVKQOX2T9L&)_%>F:='=>*/!]M/#,EWJ&E2Z2D9346MIO\\S]G[X]?$_\
M97^./PX^//P=U.Z\,?%OX4>(%US2I)1>)$MW%:7NDZYX9U[3G",-,U[2;_5?
M#VHVFHP2QM;ZA=*R .K+_7'#\L-XG>%-7A^GB%+/<MPU+#SHU7%592P:A5P;
MHQ4W.I3C"E'VC?):$Y.ESS@XK\:Q]'$<,\51Q\H2>%Q=6M-NCK)0JVBW4YU"
M,5'F;?ORV=TVS_9[MVWQJ2%QE@I!RC(A(4C&&7 !# L2" ,XYJ9B%+!01N))
M^F[@'/08 P!DX[XX/X4_\$W?^"]O['?[=G@_1='\5>,-"^ ?[05I:V-KXO\
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M]BGQ%X*\20V-Q]EOIM#\4?$;P;HNJ):7!240W+V-Y<+!.8I3!(ROL/*GB?\
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M**)((XH$CC@CC2*.*,1HBQ)&N5C6-55!&IVJ$ 'R@5;/WE_X%_*F+]\?0?\
MH-?F'$O%&>\7YE4S7/<;+$UI_P *C"/LL/AXW^"C2C)PBK**;Y>:22YI-))?
M5Y;EF$RK#PP^$HTX1BK.HJ<56J:W_>5$N:=FVU=[N^^I&RJ6.2P.3T&1R2>O
?XY/H>.U%6:*^>M-Z\T5?^[+_ .31Z%WW?WO_ #/_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
